GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function.
GlycA is a novel nuclear magnetic resonance spectroscopy-measured biomarker of systemic inflammation. We determined whether GlycA is associated with incident cardiovascular disease (CVD) in men and women, examined whether this association with CVD is modified by renal function, and compared this ass...
Main Authors: | Eke G Gruppen, Ineke J Riphagen, Margery A Connelly, James D Otvos, Stephan J L Bakker, Robin P F Dullaart |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4580603?pdf=render |
Similar Items
-
GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk
by: Margery A. Connelly, et al.
Published: (2017-10-01) -
The association of novel inflammatory marker GlycA and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis (MESA).
by: Sunyoung Jang, et al.
Published: (2021-01-01) -
Association of the Composite Inflammatory Biomarker GlycA, with Exercise-Induced Changes in Body Habitus in Men and Women with Prediabetes
by: David B. Bartlett, et al.
Published: (2017-01-01) -
Increase in the Inflammatory Marker GlycA over 13 Years in Young Adults Is Associated with Poorer Cognitive Function in Midlife.
by: Irit Cohen-Manheim, et al.
Published: (2015-01-01) -
GlycA Levels during the Earliest Stages of Rheumatoid Arthritis: Potential Use as a Biomarker of Subclinical Cardiovascular Disease
by: Javier Rodríguez-Carrio, et al.
Published: (2020-08-01)